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Summary   An endogenous molecular-cellular network for both normal and abnormal 
functions is assumed to exist.  This endogenous network forms a nonlinear stochastic 
dynamical system, with many stable attractors in its functional landscape. Normal or 
abnormal robust states can be decided by this network in a manner similar to the neural 
network.  In this context cancer is hypothesized as one of its robust intrinsic states.   
 
This hypothesis implies that a nonlinear stochastic mathematical cancer model is 
constructible based on available experimental data and its quantitative prediction is 
directly testable.  Within such model the genesis and progression of cancer may be 
viewed as stochastic transitions between different attractors. Thus it further suggests that 
progressions are not arbitrary. Other important issues on cancer, such as genetic vs 
epigenetics, double-edge effect, dormancy, are discussed in the light of present 
hypothesis. A different set of strategies for cancer prevention, cure, and care, is therefore 
suggested.                    
(For reference, please cite the published version of this article in press as:  
Ao P, et al., Cancer as robust intrinsic state of endogenous molecular-cellular network 
shaped by evolution, Med Hypotheses (2007), doi:10.1016/j.mehy.2007.03.043 ) 
 
 
Introduction 
 
Cancer as an enigma has been with humanity since the time unmemorable. It was 
recorded very early on in our written history [1]. In an 1806 issue of the Edinburgh 
Medical and Surgical Journal, 13 insightful and surprisingly modern-looking questions 
on cancer had already been formulated [2]. Since then there has been a tremendous 
progress in cancer research, particularly in elucidating its molecular, cellular, and 
epidemical connections during past 40 years. This exponential growth of molecular and 
cellular knowledge is aptly demonstrated by two classical cancer monographs, a two-
volume set around 1970 [3] and a marvelous informative and updated one in 2006 [4]. 
Many facets of cancer can now be addressed with confidence. Nevertheless, the essential 
part of those 13 questions still remains open. In order to motivate a synthetic 
understanding of cancer, 7 questions have been recently formulated in the form of 
dichotomy [5], which clearly summarized the current state of art. 
 
Despite such a long and bewildering history on cancer, it appears to us that the time to 
squarely face this disease computationally is coming. In the following we propose a 
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hypothesis based on the existence of an endogenous molecular and cellular network. This 
endogenous network functions to cope with ever-changing living conditions: starvation, 
stress caused by change in habitants, sudden availability of abundant foods, infection, 
illness, wound, etc, shaped by hundreds of million year evolution of multi-cellular 
organisms [1]. Some of its essential pathways and modules may even be traced billions of 
years back to single cell organism stage.  We will try to demonstrate that it can provide 
an overarch framework to understand cancer, to provide a guidance for its prevention, 
cure, and care. Through its validation, revision and extension, or through its falsification 
and possibly ultimate rejection, a better understanding and an eventual cancer theory may 
be reached.   
 
 
Hypothesis 
 
The hypothesis may be formulated as follows: 
The molecular and cellular agents, such as oncogenes and suppressor genes, and related 
growth factors, hormones, cytokines, etc, form a nonlinear, stochastic, and collective 
dynamical network, the endogenous molecular-cellular network. This endogenous 
network may be specified by the expression or activity levels of a minimum set of 
endogenous agents, resulting in a high dimensional stochastic dynamical system. The 
nonlinear dynamical interactions among the endogenous agents can generate many 
locally stable states with obvious or non-obvious biological functions. The endogenous 
network may stay in any of such stable state for a considerably long time. In this manner 
the endogenous network is able to autonomously decide its operational functioning state. 
Some states may be normal, such as cell growth, apoptosis, arresting, etc. Others may be 
abnormal, such as growth with elevated immune response and high energy consumption, 
likely the signature of cancer, or of still useful functions to deal with occasional stressful 
situations. The stochasticity may accidentally cause a transition from one stable state to 
another. If with a given condition the endogenous network is in a state not optimized for 
the interest of whole organism, the organism is “sick”, though this state might be 
“normal” under other conditions. Through the identifying agents of this endogenous 
network, the delineating of its wiring rules among endogenous agents, and the elucidating 
its global dynamical properties, a systems understanding of both normal and abnormal 
behaviors on how a tissue functions may be reached. In short, cancer is proposed as an 
intrinsic robust state of the endogenous network not optimized for the interest of whole 
organism. 
 
There are 3 immediate and clarifying questions to be addressed.  
 
1) Does such endogenous network exist?   
Since the discovery of the first oncogene in 1970’s [6], an impressive array of oncogenes 
and their suppressors have been discovered, covering almost all aspects of molecular and 
cellular functions. The existence of such a network has been repeatedly proposed and 
updated [7-9]. The recent monograph on cancer [4] again shows its existence. With this 
understanding, because those oncogenes and suppressor genes have normal functions and 
they are parts of endogenous molecular-cellular network, the terms such as “oncogenes” 
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are somewhat misleading. They are among the key endogenous agents perhaps 
indispensable for a given tissue. 
 
2) How does such a nonlinear stochastic dynamical network make its own decision?  
Until we have a rigorous mathematical model, questions of this kind may always be with 
us. Nevertheless, we envisage that the general working of such endogenous network is 
similar to how the neural network of the brain works. At least two versions of nonlinear 
dynamical approaches for neural network have been proposed and have been seriously 
studied both experimentally and theoretically with varied degrees of success: one via a 
potential function [10] and other via chaotic attractors [11,12]. We further point out that 
the recent developments in mathematical tools on stochastic processes [13-17] provide a 
unified framework to make use of both approaches. The landscapes of multiple 
dimensional biological systems in stochastic environments have been explicitly studied 
recently, for example, for genetic switches [18-21], cell cycle [22,23], signal transduction 
pathways [24-26]. 
 
3) What would be the essential parts of the endogenous network?  
We envisage that the oncogenes and other molecular and cellular agents first form 
pathways and modules. The pathways and modules then cross talk to each other to form 
the endogenous network. Such a hierarchical structure is similar to the modular 
organization principle discussed in Ref. [27]. The essential pathways and modules are 
illustrated in Fig. 1. We refrain here from drawing a detailed cross-talk wiring diagram, 
because the precise information on such autonomous endogenous network remains to be 
obtained from literature. Nevertheless, interesting readers may consult, for example, 
Fig.2 of Ref.[8] for an idea of such diagram along the input-output reasoning, where 
many essential endogenous agents were also listed, and the Fig. 9 of Ref.[9] which is 
more close to what envisaged here. 
 
 
 
Figure 1.The minimum set of pathways and modules of the endogenous network.  
Endogenous molecular and cellular agents first form pathways and modules. Pathways and modules cross 
talk to each other to form the endogenous network.  
Apoptosis
Immune response 
Metabolism 
Growth factors and receptors 
Ras-MAPK pathway 
PTEN-Akt pathway 
Cell cycle 
Myc-p53 pathway 
Hormones and receptors Invasion and metastasis  
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Taking prostate cancer as a specific illustration, the molecular and cellular agents are, for 
example, E2F, pRb, and CyclinE/Cdk2 in cell cycle; PTEN and Akt in PTEN-Ark 
pathway; HIF in metabolism module; Androgen in hormone module; IGF-1 and VEGF in 
growth factor module; Myc and p53 in the Myc-p53 pathway;  Ras and MAPK in Ras-
MARK pathway; E-cadherin in invasion and metastasis pathway; NF-κB, TNF-α, and IL-
10 for immune response module; and cytochrome c, Bad, caspace 3, Bcl-2, and XIAP for 
apoptosis module, already more than 20 endogenous agents. More can be easily listed, 
already discussed in Ref.[4]. 
 
 
Implications 
 
It is clear that even above limited set of molecular and cellular agents in the endogenous 
network cannot be all produced within a single cell. This fact alone evidently suggests 
that the network properties can be affected both genetically, such as mutations, and 
epidemiologically, such as by other tissues. Therefore, the postulation of such 
endogenous network to understand cancer immediately provides a possible platform to 
understand the dichotomy between whether cancer is a genetic disease [28-32] or an 
epigenetic disease [33-37].  
 
In the following we further discuss the compatibility of the proposed framework with a 
few pronounced observations on cancer based on a general and qualitative consideration 
of the hypothesis. We emphasize what will be demonstrated is plausibility, not precise 
and realistic quantitative explanations which have to be based on explicit mathematical 
models. 
 
Let us begin with the possible number of locally stable states in the functional landscape 
of such endogenous network.  As alluded above, there are at least 20 endogenous agents. 
It is known that mutual inhibiting or activating interactions are abundant in molecular and 
cellular pathways and modules, such E2F and CyclinE/Cdk2 [38] or cytochrome c and 
caspace 3 [39], a dynamical reciprocity recognized long ago [40]. Such a nonlinear and 
feedback interaction typically forms a bi-stable switch with 2 locally stable states. The 
classical example is the phage lambda genetic switch [41,18]. For a matter of 
demonstration, we may simply assume that there are, for example, 5 such independent 
effective dynamical reciprocal pairs formed by above 20 endogenous agents. Formation 
of such dynamical reciprocity pairs may take 10 endogenous agents. The activating-
inhibiting pairs are also abundant in endogenous networks, such as MAPK----MAP [42] 
and iκB----NF-κB [43-44]. Their action may be regarded as buffering and regulation of 
those dynamical reciprocity pairs. Each activating-inhibiting pair normally forms one 
stable state. We may assume that there are effectively 5 of them, perhaps taking another 
10 endogenous agents. The existence of many such elementary regulatory circuits has 
been demonstrated to be abundant in biological networks [45-47]. Then based on above 
hypothetic estimation of dynamical reciprocity and activating-inhibiting pairs, the total 
number of stable states, or the attractive basins in the functional landscape, may be 
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2x2x2x2x2x1x1x1x1x1 = 25 x 15 = 32. This number is by no means what should be in a 
real endogenous network, because how the endogenous agents are actually wired together 
would strongly affect this number. Nevertheless, we take this number as an anchor to 
indicate the possible number of stable states in the functional landscape of the 
endogenous network. For cases to be discussed below the conclusions are largely 
independent of the exact number of stable states.  
 
Given the existence of multiple stable states, we may speculate that there are some states 
may correspond to healthy states under normal conditions, some to deal with rare 
stressful situations, and a few others would be the “disease” states or abnormal states. A 
schematic illustration of the functional landscape along a route going through minima and 
saddle points is in Fig. 2. Here it may be worthwhile to mention that the landscape idea 
has already explored early on in biology in other contexts: for example, the adaptive 
landscape in population genetics [48] and the developmental landscape in developmental 
biology [49]. Such idea has already been considered by molecular biologists [50]. 
 
With the existence of such functional landscape with multiple local stable states, the 
dormancy of neoplasma may be easily explained [51-53]: The endogenous network is in 
a state close to, but not in, the cancerous state. It shares many features of cancer. Because 
of the local stability as illustrated in Fig. 2, it can stay there for a very long time, thus the 
dormancy.  Such “dormancy”, or lysogenic state, has already been well known for a 
simple organism, phage lambda. Even after mutations in its genome, it may still stay in 
the lysogenic state for many generations [41,54]. Thus, the existence of functional 
landscape with multiple stable states explains the robustness widely observed in 
biological systems [18,24,55-60]. The existence of such multiple stable states may also 
corroborate well with the observations that cancer takes multiple steps [61]: If regarding 
moving from one stable state to another as one step. 
 
 
Figure 2. Three typical situations of the functional landscape. The vertical scale illustrates the relative 
stability of robust states, healthy, tumor and others, in the multiple dimensional state space. a) The healthy 
state is a globally stable under normal conditions; b) Due to genetic and epidemiologic influence on the 
endogenous network, tumor or cancer states may become more stable than healthy state. Such metastable 
healthy state may still have a long life time for the whole organism being viable; c) A very “damaged” 
endogenous network may not be able to produce a locally stable healthy state.  
a: preventable/curable c: incurable/ untreatable b: curable/treatable 
Other robust 
states 
Healthy state 
Tumor 
state 
Other robust 
states 
Other robust 
states 
Tumor 
state 
Tumor 
state 
Healthy state 
Healthy state 
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The existence of stable states in the functional landscape further suggests that the 
navigation from one stable state to another may not be arbitrary. There are preferred 
routes, most likely those passing through saddle points. This natural and qualitative 
consequence of the present mathematical consideration implies that the genesis and 
progression of cancer may have patterns. If this is true, present modeling methodology 
may suggest an alternative set of strategies for cancer prevention, cure, and care. It 
should be pointed out that such behaviors have already been noticed clinically [62]. 
Though the computational effort on such multiple-dimensional functional landscape may 
be heavy, it is an effort worthy pursuing.  
 
The fact that the endogenous network can be influenced by both genetic and 
epidemiologic factors, as illustrated by three typical situations in Fig. 2 and discussed in 
its caption, implies that the network wiring can be changed, the network flexibility 
already noticed [63]. It certainly implies that other factors, such as chaperones, can also 
influence its functional landscape [64]. For example, certain level of chaperones can 
lower the barrier and make the local minimum shallower, resulting in larger fluctuations.  
Nevertheless, we believe the backbone and essential structure of the endogenous network 
would remain the same and is conserved, because it has been shaped by millions, or even 
billions, years of evolution. During the lifetime of an organism, there is a little chance of 
any major modification of the essential structure of the endogenous network. 
 
Because interactions among endogenous agents are nonlinear, a few key endogenous 
agents may have self-amplifying effects. This self-amplifying may lead to a locally stable 
state in the functional landscape. Such the self-trapping effect is known in nonlinear 
dynamics. Those behaviors may correspond to the observed “oncogene addiction” [65]. 
 
It is known that the differentiation of stem cell is stochastic with multiple intermediate 
stable states [66-70]. The present functional landscape has the capacity to explain those 
observations: The navigating of endogenous network through those stable states in 
functional landscape may correspond to what observed. This ability of navigating through 
the functional landscape may suggest itself as a guiding principle to look for strategies of 
cure and care and well as prevention.  Similar idea has been elaborated in literature [62], 
already discussed above. 
 
Consider a possible extreme situation which appears critical important from basic 
biological consideration for present formulation, though it might not be clinically 
important. The existence of multiple states in functional landscape suggests that there can 
be a nonzero probability that cancer be formed without any genetic defect. In the same 
vein of reasoning, there can be a nonzero probability of cancer regression without any 
major interventions.  We do not aware of any solid experimental evidence on those two 
suggestions, but it would be interesting to know how they would have been vindicated by 
experimental observation and clinical data. 
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We emphasize that there should be a minimum set of endogenous molecular and cellular 
agents in order to give a comprehensive description of the endogenous network. Such 
number is perhaps no less than 20, as indicated by above prostate cancer example. If one 
would only focus on one or a few endogenous agents, or one pathway and module, 
ambiguity may be resulted in. For example, cell proliferation or death can happen with 
either lower or higher immune activity.  This may be related to the well known double-
edge effect [71-72].  There exists another possibility: Because the dynamics is stochastic, 
a deterministic set of values for the endogenous agents may not provide us with the 
crucial information.  The distributions and correlations among the endogenous agents 
should be measured experimentally or computed theoretically in order to give a better 
characterization of the endogenous network. There exists an even more intriguing 
possibility which may make the interpretation of experimental data more difficult.  
Because the endogenous agents are highly correlated to each other, a better description 
may be a set of collective variables of those endogenous agents. If such situation occurs, 
the information on the distributions and correlations of endogenous agents, if we do not 
have a good idea of what the collective variables were, may not provide an immediate 
characterization of the endogenous network. One needs to look for such collective 
variables. The present proposal may provide a mathematical and computational tool to 
address this last question, too. 
 
Given all above considerations, it appears that the hypothesis of cancer as robust intrinsic 
state of the endogenous molecular-cellular network provides a framework to address all 7 
dichotomies analyzed in Ref.[5]. 
 
 
Conclusions 
 
We have proposed to understand cancer as robust intrinsic state of the endogenous 
molecular-cellular network in a manner similar to the neural dynamical modeling. A 
stochastic mathematical modeling scheme is implied in our proposal. We have 
demonstrated that there is enough experimental evidence to support the existence of such 
endogenous network. Discussions on immediate consequences of our proposals have 
indicated a qualitative agreement with all major observations on cancer.  Here we further 
suggest that if this proposal is true for cancer, it may also be true for other complex 
diseases such as diabetes II. The immediate task is then to build from available 
experimental data a mathematically relative simple but biologically nontrivial 
quantitative model, to perform the analysis of such model as discussed above, to compare 
its predictions to experimental observations, to further improve the mathematical 
modeling.  Through such interactive processes between experimental and theoretical 
efforts, a better understand of cancer should be reached. 
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Note on literature:  Hundreds of billions dollars have already been spent on cancer world wide. 
The number of existing papers is measured in million. Therefore, no attempt had been made to 
provide a complete literature: We simply could be able to do that. Nevertheless, the authors 
believe that a good part of the current cancer research spirit has been captured, which leads to the 
network and evolution hypothesis presented in the text. In the light of such understanding, the 
authors will very much appreciate suggestions, comments and critiques on our omissions, 
ignorance, and misunderstandings (contact: aoping@u.washington.edu).    
 
 
Appendix.  13 questions and 7 dichotomies on cancer.  
 
Questions formulated 200 years ago are here. For a penetration discussion, see Ref.[2]. 
    “1) What are the diagnostic signs of cancer? 
      2) Does any alteration in the structure of a part take place, preceding that more 
obvious change which is called cancer; and if there be an alteration, what is its nature? 
      3) Is cancer always an original and primary disease; or may other diseases degenerate 
into cancer? 
      4) Are there any proofs of cancer being an hereditary disease? 
      5) Are there any proofs of cancer being a contagious disease? 
      6) Is there any well-marked relation between cancer and other diseases? If there be, 
what are those diseases to which it bears the nearest resemblance in its origin, progress, 
and termination? 
      7) May cancer be regarded at any period, or under any circumstances, merely as a 
local disease? Or does the existence of cancer in one part afford a presumption that there 
is a tendency to a similar morbid alteration in other parts of the animal system? 
      8) Has climate or local situation any influence in rendering the human constitution 
more or less liable to cancer, under any form, or in any part? 
      9) Is there any particular temperament of body more liable to be affected with cancer 
than others? If there be, what is the nature of that temperament? 
      10) Are brute creatures subject to any disease resembling cancer in human body? 
      11) Is there any period of life absolutely exempt from the attack of this disease?  
      12) Are the lymphatic glands even affected primarily in this disease? 
      13) Is cancer, under any circumstances, susceptible of a natural cure?” 
 
The dichotomies are listed here for a quick comparison. Please check Sporn’s beautiful 
elaborations [5].  
    “i) ‘The disease is cancer’ versus ‘the disease is really carcinogenesis’; 
      ii) ‘Emphasis on cure of end-stage disease’ versus ‘prevention of early disease 
progression’; 
      iii) ‘Cancer is a genetic disease’ versus ‘cancer is also an epigenetic disease’; 
      iv) ‘New emphasis on transgenic mouse models with single gene disruption’ versus 
‘classical carcinogenesis models that damage multiple genes’; 
      v) ‘New emphasis on monofunctional agents’ versus ‘need for multifunctional agents’ 
      vi) ‘Reductionism’ versus ‘the whole can be greater than the sum of its parts’; 
      vii) ‘Hypothesis-driven research’ versus ‘the need for observational research’.”  
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